A thirty-five nucleotides BCR-ABL1 insertion mutation of controversial significance confers resistance to imatinib in a patient with chronic myeloid leukemia (CML)

Silvia Marcé, Montserrat Cortés, Lurdes Zamora, Marta Cabezón, Javier Grau, Fuensanta Millá, Evarist Feliu

Research output: Contribution to journalArticleResearchpeer-review

4 Citations (Scopus)

Fingerprint

Dive into the research topics of 'A thirty-five nucleotides BCR-ABL1 insertion mutation of controversial significance confers resistance to imatinib in a patient with chronic myeloid leukemia (CML)'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds